Close Menu

Canada has launched its Canadian Partnership for Tomorrow Project that aims to follow 300,000 adults over the age of 35 for the next 30 years to study causes of cancer. Along the way, researchers will be collecting blood, fecal, saliva, toenail, and urine samples as well as asking about diet, environmental conditions, and physical fitness.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.